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ABSTRACT
The use of Sphingomyelin to protect against UV induced DNA damage in Human
Keratinocytes
Kevin Campbell

Non melanoma skin cancer (NMSC) is a serious condition caused by chronic
ultraviolet (UV) exposure that leads to DNA damage in skin. UV radiation has the
potential to lead to DNA damage, which triggers biochemical pathways within a cell. The
result is that the cell either undergoes cell cycle arrest, giving the cell time to repair DNA
damage, or apoptosis. Sunscreen is the most commonly used treatment for preventing UV
induced skin damage, but it involves a number of undesirable and toxic side effects
including damaging the dermis, premature aging of skin and underweight child births.
This has led to interest in finding safer alternatives to prevent UV damage without the
negative side effects of sunscreen. In particular, bovine milk sphingomyelin (SM) is a
compound that has the potential to protect against UV damage without any of the
dangerous side effects of sunscreen. Here we present the use of SM for UV protection of
human keratinocytes (KRTs) to prevent DNA mutations that result from UV exposure. In
particular, analysis of the expression of DNA damage biomarkers p21 and p53 was done
to determine the potential of SM to prevent DNA damage associated with UV exposure.
Both non-SM treated KRTs and KRTs treated with 0.1% SM media 24 hours prior to UV
radiation were fixed and IF-stained at 24 hours following 40 mJ/cm2 of UV exposure.
Significant differences in both p21 and p53 were observed between the SM treated and
non-SM treated cells at the UV dosage level (via t-test; p<0.05). These findings suggest
iv

that 0.1% bovine SM treatment may impart photoprotective properties to KRTs and thus
prevent UV associated DNA damage, which could potentially support further research
into SM as a treatment to safely prevent the onset of non melanoma skin cancer.

Keywords: Keratinocytes, p21, p53, UV radiation, sphingomyelin, skin cancer
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Chapter 1: Introduction
Non melanoma skin cancer (NMSC) is the most prevalent form of cancer and is
typically caused by ultraviolet (UV) radiation. In the United States alone, NMSC
constitutes the largest percentage of new cancer cases with nearly 3.5 million new
patients annually [1, 2]. UV exposure leads to the formation of radical oxygen species,
which are known to cause DNA damage, and the formation of thymine and pyrimidine
dimers (See Figure 1.1) [3,4]. Following UV induced DNA damage, the cell will activate
the DNA damage repair pathway [2]. Additional DNA damage increases the probability
that DNA repair errors will occur resulting in mutations, potentially leading to the
formation of NMSC [5].

Figure 1.1 UV Induced DNA damage. UV radiation causes thymine and
pyrimidine dimer formation which leads to DNA damage repair [3].

The two most common forms of skin cancer are basal and squamous cell
carcinoma. Basal cell carcinoma constitutes nearly 80% of all NMSC cases and nearly
two and a quarter million new diagnoses of basal skin cancer are expected in the US
within the next year [6]. Squamous cell carcinoma is the next most common form of
NMSC, afflicting nearly 20% of all skin cancer patients and this form is much more
likely to metastasize than basal cell carcinoma [6]. The number of basal and squamous
1

cell carcinoma cases are also increasing, with 350% more diagnosed patients observed
annually between 1994 and 2006 [7]. The large increase in patients diagnosed with basal
or squamous cancer now drives new research on how to safely prevent skin cancer.
One of the most common treatments available to prevent skin cancer formation is
sunscreen. However, limitations of sunscreen include a number of toxic and undesirable
side effects. Sunscreen includes heavy metal ions like zinc oxide and titanium
nanoparticles that cause oxidative damage and can kill healthy cells [3,8]. Furthermore,
pregnant women using sunscreens with oxybenzone are at risk of giving birth to
underweight children [4]. These undesirable side effects have sparked interest at looking
at alternatives to sunscreen. Previous work has shown that sphingomyelin (SM), a bovine
milk phospholipid, has the potential to protect against UV damage without any of the
toxic side effects associated with sunscreen [5]. Low concentrations of SM could
potentially protect against UV damage by binding and dissolving lipid rafts in the plasma
membrane thereby preventing the formation of radical oxygen species during UV
exposure, which are carcinogenic and known to cause DNA damage [2, 6]. The negative
side effects associated with current treatments available to prevent skin cancer and the
potential of SM has prompted interest in determining if SM can protect skin from UV
damage.
Therefore, in this study we examine human keratinocytes (KRT) to determine if
SM can prevent UV induced DNA damage. Specifically, the cyclin-dependent kinase
inhibitor p21 and the tumor suppressor gene p53 has been shown to be up-regulated in
response to DNA damage [7]. Nuclear expression of p53 occurs nearly immediately
following UV induced DNA damage and increased expression of p53 has been linked to
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G2-phase arrest preventing the proliferation of potentially cancerous cells [9,10,11]. The
nuclear expression of the cyclin kinase inhibitor p21 has also been shown to be increased
in the presence of DNA damage and also leads to cell cycle arrest in cells expressing
DNA damage, making the p53 and p21 proteins an ideal DNA damage biomarker to
assess SM’s effectiveness [12,13]. It is hypothesized SM treated KRTs will reduce DNA
damage following UV exposure, which will lead to a decrease in the expression of p21
and p53 compared to KRTs without SM in the presence of UV. This study could
potentially support further research into SM as a treatment to safely prevent the onset of
NMSC. Here we studied p21 and p53 expression in KRTs exposed to UV radiation to
determine the capacity of SM to protect against UV induced DNA damage and potential
to prevent skin cancer. It is hypothesized that SM treated KRTs will reduce the
expression of both p21 and p53 compared to KRTs without SM in the presence of UV,
which could potentially support further research into SM as a treatment to safely prevent
the onset of NMSC.

3

Chapter 2: Background:
2.1 Structure and Function of the Epidermis
The integument, or skin, is the largest organ in the body, constituting about 7% of
the total body weight and approaching 2 m2 of surface area in a typical adult [14]. Skin is
composed from a stratified cellular epidermis surface layer, a dermis layer and a layer of
subcutaneous fat separating striated muscle [14]. These layers provide a mechanical
barrier against the outside world, preventing materials from entering or leaving the body.
Skin also is responsible for realizing endogenous antibiotics to protect against microbials,
production of melanin to prevent UV associated DNA damage, production of vitamin D
along with other metabolic products and thermoregulation to control heat loss [14]. Each
layer of skin has a unique composition and is responsible for specific functions to
maintain homeostasis.
The outermost layer of skin is the epidermis layer and consists of keratinocytes
which provide hydrodynamic regulation, innate immune response and melanin
production [14]. The epidermis layer consists of multiple layers, including stratum
corneum, granular layer, spinous layer, basal layer and a basement membrane (See Figure
2.1) [14]. The stratum corneum and granular layers are comprised of differentiated
keratinocytes, which form a more flatten like structure due to the cytoskeleton being
created from keratin intermediate filaments [14]. These differentiated keratinocytes
within the stratum corneum are called corneocytes and have lost their nuclei and
cytoplasmic organelles [14]. Corneocytes form a highly insoluble envelope within their
plasma membranes by cross-linking soluble protein precursors and incorporation several
lipids released from undifferentiated keratinocytes within lower layers of the epidermis
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[14]. This hydrophobic region of the stratum corneum helps control water loss or
absorption through the skin [14]. The epidermis also consists of melanocytes and
Langerhans’ cells, which are responsible for producing melanin and antibiotics
respectively [14]. Melanin plays an important role in preventing UV associated DNA
damage and Langerhans’ cells are antigen presenting cells which have a role in skin’s
adaptive immune response [14]. The dermis layer is below the epidermis and is
connected via the basement membrane.

Figure 2.1 Structure of the human epidermis [14].
The dermis layer provides structural support for the skin and provides motor control,
thermoregulation and additional hydration control [14]. The dermis is approximately 0.5
mm to 5 mm thick and is primarily composed of collagen and elastic tissue [14].
5

Approximately 80-85% of the weight of the dermis is attributed to collagen [14]. These
collagen fibrils are extremely durable and provide skin with its tensile strength [14].
Elastic fibers account for about 2-4% of the extracellular matrix within the dermis and is
responsible for the elasticity and resilience of skin [14]. Fibronectins, fibulins and
integrins are responsible for cell adhesion and motility. The motor innervation is
controlled automatically within the dermis and allows for control of the sweet glands and
smooth muscles [14]. Blood vessels and the eccrine sweat glands occupy the dermis,
which allows for thermoregulation through perspiration and vasodilation/constriction
[14]. The region between both the collagen and elastic tissue is occupied by
glycosaminoglycan and proteoglycan macromolecules, which are very hydrophilic and
provide high regions of water affinity. This helps maintain water within the dermis,
providing additional hydrodynamic regulation.
Subcutaneous fat is beneath the dermis and provides support as well energy reserves
and hormone regulation [14]. Nearly 80% of the total body fat is found in subcutaneous
tissue in non-obese individuals. This subcutaneous fat provides support against trauma
related injuries and provides a significant deposit of calorie reserve. In addition to
preventing injury and energy storage, the subcutaneous fat beneath the dermis also has an
endocrine function including the release of leptin, which regulates hunger and energy
metabolism [14].

6

2.2 Non Melanoma Skin Cancer (NMSC)
2.2.1 Types and Diagnoses
NMSC is a serious condition and includes cutaneous lymphomas, Merkel-cell
carcinoma and adnexal tumors, though basal-cell carcinomas (BCC) and squamous-cell
carcinomas (SCC) are the primary forms of NMSC [15]. NMSC is the most prevalent
skin cancer and there are over two million new cases of NMSC each year in the United
States alone. BCC is the most common form of NMSC, constituting about 70-80% of
new NMSC cases [15]. SCC cases are less prevalent than BCC, constituting nearly 2030% of total NMSC cases, though SCC is much more likely to metastasize than BCC
[15]. The number of NMSC have been steadily increasing since 1960 worldwide, with an
average 3-8% increase in incidents per year [15].
BCC usually appear as small and translucent discolorations on the skin of patients
[15]. The head and neck are the most common regions of BCC formation, constituting
nearly 80% of all BCC cases. Clinical diagnosis is typically straightforward for the head
and neck region and involves a skin biopsy. Formation of superficial BCC on the trunk of
patients is rarer, but has been shown be both increasing and harder to diagnosis due to
difficulty defining boarders of the carcinoma and distinguishing BCC from other possible
disease [15]. The more common types of BCC include rodent ulcers, nodular, superficial,
morphoeic and pigmented carcinoma (See Figure 2.2) [15].
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Figure 2.2 Clinical cases of BCC. (A) Rodent Ulcer. (B) Nodular. (C)
Superficial. (D) Morphoeic. (E) Pigmented [15].
SCC are more likely to be malignant and can have precursor legions including
actinic keratoses and Bowen’s disease [15]. Actinic keratosis are legions that can indicate
high UV exposure and an increased risk of being diagnosed with SCC (See Figure 2.3)
[15]. Although the formation of invasive SCC from single actinic keratoses is
approximately 1-10% over the course of 10 years, the risk of forming SCC increases with
more actinic keratosis [15]. Lesions from Bowen’s disease usually are present in regions
of sun exposed areas and are slowly enlarging crusted plaques (See Figure 2.3) [15].
These legions are typically hard to define and have a 3-5% chance of progressing to SCC
[15]. Histopathological examination is the most common method of diagnosing NMSC,
but non-invasive screening including dermoscopy, ultrasound, optical coherence
tomography and in-vivo confocal microscopy have had success diagnosing NMSC [15].
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Figure 2.3 Clinical cases of precursor legions and SCC. (A) Actinic Keratosis. (B)
Bowen’s Disease. (C) Keratoacanthoma. (D) SCC. [15]
2.2.2 UV Radiation
Exposure to the sun’s radiation is the primary cause of NMSC [16]. The solar
spectrum consists of UV radiation, visible light and infrared, with UV only accounting
for 5% of the total sunlight reaching earth [16]. UV radiation is split into UVA (320nm400nm), UVB (290nm-320nm) and UVC (100nm-290nm). Although the position of the
sun above the horizon, the time of day, day of the year and geographical location affects
UV exposure, typically UVA constitutes 94% of total terrestrial UV and UVB constitutes
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6% [16]. Radical oxygen species, reactive nitrogen species and reactive sulfur species in
the upper atmosphere are responsible for absorbing all UVC radiation, which is the most
potent DNA damaging UV region, and most of the UVB region [16]. Even though UVA
is the most abundant terrestrial UV, UVB is much more likely to lead to DNA damage
[16]. As a result, UVB has been liked to causing nearly 80% of NMSC and is used in the
course of this study to induce DNA damage [16].
UVB radiation has been linked to causing DNA damage and NMSC. UV
radiation has been found to cause cyclobutane pyrimidine dimers from adjacent
pyrimidine bases in DNA strands [17]. In addition, another dimer at the di-pyrimidine
site, the 6-4 photoproduct, has been identified as a product of UVB radiation [17]. These
dimers are removed and repaired with a process called nucleotide excision repair, though
higher frequency of these dimers has been linked to DNA mutations (See Figure 2.4)
[17]. Frequent exposure to UVB radiation has also been associated with mutations with
the TP53 tumor gene, which is responsible for the transcription of p53 and later
downstream cell cycle arrest activating proteins [17]. Mutations with the TP53 tumor
gene and consequently the p53 protein impedes the cells ability to repair DNA damage,
increasing the risk of forming NMSC [17].
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Figure 2.4 Different dimer formations resulting from UVB exposure [18].
Although UVB causes the majority of DNA damage, UVA has also been
associated to indirectly cause DNA damage. The thiopurine 6-mercaptopurine absorbs in
the UVA region and forms radical oxygen species [19]. Radical oxygen species have well
understood mechanism of causing DNA damage, and abrupt increases in these reactive
species can lead to oxidative stress and mutagenic DNA legions [19]. The cell does have
pathways to neutralize radical oxygen species, but rapid changes in these radical species
can cause DNA damage prior to neutralization [19]. UV radiation is a potent cause of
NMSC through the DNA damage caused directly by UVB and indirectly through the
formation of radical oxygen species with UVA exposure.
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2.2.3 Pathogenesis
Extensive exposure to the sun’s radiation is linked to causing NMSC [20]. In
particular, UV radiation from the sun could cause NMSC by causing mutations in the
DNA, inducing immune-suppression that might inhibit tumor prevention and could also
lead to persistent infection with Human Papilloma Viruses [20]. Figure 2.5 shows how
UV exposure can increase the risk of forming NMSC by damaging DNA and activating
cell cycle arrest/DNA repair and weakening the immune system against subsequent
infections [20]. Aging was also found to decrease the capacity to repair DNA damage
[20]. Although the mechanism for the suppression of the immune response is not clearly
understood, there is strong evidence linking the reduction of the immune response with
prolonged UV exposure [20]. In addition, the risk for forming NMSC increases with age,
as the immune system and capacity to repair DNA decreases with older patients [20].
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Figure 2.5 Potential pathways to the development of NMSC [20]
Mutations in specific regions of the genome increase the risk of NMSC. Over half
of the cases of BCC have been linked with mutations in the Hedgehog pathway related
genes, especially PTCH1, in animal models [4]. Mutations in the p53 tumor suppressor
gene are extremely common in animals with precancerous lesions and SCC [4]. These
mutations have not only been linked to carcinogenesis, but also mutagenesis and
premature aging [4]. Direct DNA damage is repaired with nucleotide excision repair
pathway and DNA damage from radical oxygen species are repaired via base excision
repair [4]. However, mutations in the regulatory genes and a reduction of the immune
response increases the likelihood of NMSC formation [4].
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2.2.4 Prevention
There a currently numerous methods for preventing the onset of NMSC. Some of
these methods include avoiding sun exposure between 10 am to 4 pm, wearing sunprotective clothing, using sunscreen with a sun-protection factor greater than 15 and
avoiding artificial sources of UV [21]. Sunscreen is one of the most common treatments
available to prevent NMSC, and has been shown to inhibit the transmission of UV by
absorbing, scattering or reflecting UV radiation depending on the present active
ingredients [22]. Sunscreens typically contain either organic or inorganic active
ingredients. Organic sunscreens are usually derivates of salicylates, p-aminobenzoates,
dibenzoylmethanes, cinnamates, camphors, benzophenones or anthranilates [22]. These
organic components will absorb the higher energy UV and will undergo a chemical
reaction releasing heat [22]. Inorganic sunscreens typically include microfine particles of
titanium dioxide and zinc oxide coated with silicone, fatty acids or oxides of aluminum,
silicon or zirconium [22]. These particles are designed to scatter and reflect UV radiation
to prevent UV radiation from reaching skin. Sunscreen has been shown to be effective
against preventing UVB exposure proportionally to the sun-protection factor. Rodent
models have shown that sunscreen reduces local immunosuppression, p53 mutations and
the formation of actinic keratosis, thereby reducing the likelihood of NMSC formation
[22].
A number of toxic and undesirable side effects limit the application of sunscreen.
A number of active components found in organic sunscreens including p-Aminobenzoic
acid, benzophenone-9 and 2-phenylbenzimidazole-5-sulfonic acid which were found to
be potentially carcinogenic [22]. When tested with in vitro cytotoxicity studies they were
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found to induce cyclobutane dimers in mammalian DNA and adducts with thymine and
thymidine following UV exposure [23]. In addition, components like oxybenzone are
commonly used in sunscreens and is listed as very hazardous by the center for disease
control and prevention [24]. Oxybenzone is also on the registry of toxic effects of
chemical substances because of the chemicals capacity to absorb through the skin and
disrupt endocrine function [24]. Mothers with high oxybenzone blood levels are at risk of
giving birth to underweight children and extended exposure to oxybenzone can also lead
to the formation of photocontact allergic reactions [25]. Titanium nanoparticles and zinc
oxide are also commonly used in sunscreens to reflect UV radiation and have also been
noted to have cytotoxicity and genotoxicity properties [8]. These toxic side effects
associated with sunscreen usage has prompted interest in finding safer alternatives to
prevent skin cancer.
2.3 Sphingomyelin
Bovine milk sphingomyelin (SM) is a phospholipid found in bovine milk which is
believed to have anticarcinogenic properties. Phospholipids make up a small percentage
(<1%) of all the lipids found in milk, with SM constituting approximately 18-20% of the
total phospholipid concentration [26]. SM is also found naturally within the outer leaflet
of the plasma membrane of cells. When triacylgyerols, including sphingomyelin, are
exposed to other cell membranes, they are incorporated into the fat globule membrane of
the cell [26]. Approximately 10% of all digested sphingomyelin is believed to escape
digestion and is transported throughout the body [27]. The addition of sphingomyelin to
the plasma membrane has been linked to having anticarcinogenic effects. In particular,
the use of sphingomyelin has been linked to acting as inhibitors of colon carcinogenesis.
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In the case of colon cancer, the incorporation of sphingomyelin within the colon was
found to reduce colon cancer incidents without any evidence of toxic side effects [28].
Interest in determining if sphingomyelin is effective against other types of cancers have
lead to further carcinogenic studies with sphingomyelin. Previous in vitro studies have
found trends that support sphingomyelin protecting keratinocytes from UV induced DNA
damage, which could have applications in protecting against skin cancer [28].

Figure 2.6 Structure of SM and ceramide [29].
SM is a polar lipid which constitutes a major component of plasma membranes
and could have pathways to prevent cancer formation. SM contains a phosphorylcholine
polar head group, a sphingosine backbone and a short region of paraffinic residues [30].
This region of paraffinic residues contain an acyl chain that is typically long and is either
16

saturated or contain many cis double bonds [30]. The structure of SM is composed of
ceramide, which is a bioactive lipid that is in equilibrium with the synthesis and
hydrolysis of SM (See figure 2.6) [30]. Ceramide has been shown to have important roles
in growth arrest, differentiation and apoptosis in many different cell types [30]. In
particular, human colon cancers have observed significant decreases in the amount of
available ceramide [30]. Restoration of ceramide in mice transfected with human colon
cancer found tumor free livers in the mice, while mice with ceramide deficiencies were
found to develop liver tumors (See figure 2.7) [30]. Increases in the ceramide levels were
believed to induce apoptosis in cancerous cells, making a ceramide a potential anti-cancer
therapy. Increases in SM have been linked to increasing ceramide, which could provide a
mechanism for how SM could impart protection against cancer formation. KRTs were
found to have a significant increase in ceramide levels after being treated with SM, which
has prompted further interest in investigating the role SM might have in preventing skin
cancer [31].
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Figure 2.7 Mice colon without ceramide treatment (A,C), mice colon histology with
Ceramide treatment (B,D) [30].
In addition to the protective properties of ceramide, SM is also believed to have
applications against skin cancer by reducing the formation of radical oxygen species
following UV exposure. Exogenous SM is believed to be passively incorporated into the
outer leaflet of the plasma membrane, where SM can provide integrity of the plasma
membrane [32]. SM is also believed to play a role in degrading GM1 Ganglioside and
cholesterol-rich microdomains (i.e lipid rafts) found within the plasma membrane (See
figure 2.8) [32]. These lipid rafts have been found to generate damaging radical oxygen
species following UVA irradiation [33]. The formation of radical oxygen species has
been found to cause DNA damage and potentially lead to the progression of cancer [34].
18

SM capacity to degrade these lipid rafts before the KRTs are exposed to UV radiation
could potentially decrease the formation of radical oxygen species following UV
exposure, leading to less UV induced DNA damage. This could support SM as an anticancer therapy by inhibiting the production of these radical oxygen species which should
lead to less DNA damage following UV radiation [34].

Figure 2.8 Example of a lipid raft microdomain [35].
2.4 Human p21 Protein
2.4.1 Overview
Human p21 protein participates in cell cycle arrest following DNA damage
allowing for DNA repair or apoptosis. The cyclin-dependent kinase inhibitor 1 protein,
also known as p21, is mediated by the tumor suppressor gene p53 and inhibits
cyclin/cyclin-dependent kinase activity [36]. The human ras gene family is composed of
at least three members, including H-ras, K-ras and N-ras which are responsible for
encoding closely related proteins called p21 [37]. This p21 gene is believed to be the link
between the activation of the tumor suppressor gene p53 and the resulting suppression of
the G1 growth phase [37]. Subsequent studies of inhibiting p21 expression found that the
G1 growth phase was not inhibited following p53 activation [36]. In addition to the role
played by p21 in causing cell cycle arrest, p21 has also been attributed to coordinating
with the DNA repair process. PCNA has been identified to activate the DNA polymerase
δ, which is involved in both DNA replication and repair [38]. Evidence has been found
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supporting p21 directly binding to PCNA and blocking the activation of DNA
polymerase δ [38]. These results provide strong evidence that p21 has an essential role in
p53 mediated cell cycle arrest and DNA repair, making p21 an ideal DNA damage
biomarker.
2.4.2 Interactions with Cyclin-CDKs
The cellular growth process of eukaryotic cells involves a growth and replication
phase, known as interphase, which is responsible for production of new organelles,
proteins and replication of DNA. This phase is further divided into a G1, S, G2, and M
phase which are characterized by cell growth, chromosome duplication, further growth
and division phase respectively. Certain DNA damage checkpoints use damage sensor
proteins including ATM, ATR, Rad17-RFC complex and the 9-1-1 complex to detect
DNA damage [39]. Following detection of DNA damage, signal transduction cascades
employ Chk1, Chk2 and Cdc25 phosphatases, which activate p53 and inactivate cyclindependent kinases to induce cell cycle arrest [39]. Checkpoints include the progression
from G1 to S phase, the intra-S checkpoint and G2 to M checkpoint [39]. Activation of a
checkpoint either leads to DNA repair mechanisms, including direct repair, base excision
repair, double strand break repair, cross link repair and nucleotide excision repair [39].
Failure to adequately repair DNA leads to apoptosis, which ensure that sever damage or
deregulated cells are destroyed [39]. These checkpoints help ensure that DNA replication
and chromosome segregation are completed with high accuracy [40].
The activation of these checkpoints requires a mechanism for inducing cell cycle
arrest to allow for DNA repair or apoptosis. The p21 protein can bind to certain cyclin
dependent kinases (Cdks) and can prevent the phosphorylation of Rb by cyclin A-Cdk2,
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cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes [41]. Further
experiments with p21 have found that p21 can inhibit nearly every member of the
cyclin/CDK family [41]. These cyclins are responsible for growth and development
during cell division. The D-type cyclins are activated due to mitogenic signals, leading to
the assembling of CDK4 and CDK6 during the G1 phase [42]. CDK activating kinases
(CAK) are required to activate these CDKs to allow for subsequent downstream
phosphorylation. Progression to further growth phases requires that cyclin D-CDK
phosphorylate Rb and sequester cyclin inhibitors including p21 (See figure 2.9) [42]. The
role of p21 in preventing cyclin kinase activity and Rb phosphorylation provides
evidence to indicate that p21 has an essential role in controlling cell cycle progression.

Figure 2.9 Roles of CDK, RB and p21 (Cip) in cell cycle progression [42].
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2.4.3 Interactions with PCNA
The process of DNA replication in eukaryotic cells is an involved process with
mechanisms to repair DNA errors. DNA replication is typically very accurate and
proceeds at 2900 base pairs per minute [43]. However, DNA legions can lead to
replication failure, requiring mechanisms to address these damaged regions [43]. The
proliferating cell nuclear antigen (PCNA) is a circular protein that encompasses DNA and
helps ensure genomic integrity by recruiting other factors to regions of DNA instability
or damage [43]. PCNA is part of the DNA sliding clamps that are composed of two
similar globular domains, linked by interdomain connecting loops [43]. This PCNA ring
is recruited in regions of DNA damage and will then attach polymerases, including DNA
polymerase δ, firmly to DNA thereby increasing the productivity of DNA polymerases
from dozens to thousands of nucleotides per minute [43]. The role PCNA has on
recruiting factors and increasing polymerase activity make PCNA an essential factor in
DNA damage repair.
The p21 protein is responsible for regulating PCNA following DNA damage. The
binding of PCNA to DNA is mediated by the C terminal of the PIP box, where p21 acts
as a competitive inhibitor thereby blocking the surface of PCNA from recruiting
polymerases [43]. Factors prohibited from PCNA binding following p21 binding include
polymerase δ, FEN-1, chromatin remodeling factor WSTF, repair protein XPG and DNA
methyltransferase [43]. This suggests that high expression of nuclear p21 expression will
cease DNA repair processes, allowing PCNA is interact with p33 and potentially conduct
apoptosis [43]. The p33 pathway binds to the N-terminal of PIP box, and has been show
to increase over tenfold in the presence of UV irradiation and induce apoptosis [43]. The
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binding of the C terminus of PCNA to inhibit the DNA repair pathway and binding of the
N terminus to induce apoptosis provide a regulatory means of p21 altering competitive
binding to determine the cell’s faith [43]. The role p21 has in directly inhibiting cell
growth and regulating apoptosis through PCNA inactivation make p21 an ideal marker to
assess UV induced DNA damage.
2.5 Human p53 Protein
The tumor suppressor gene p53 is part of the regulation process to prevent
oncogenesis. This tumor suppressor p53 protein can bind to the T antigen of SV40, which
has been found to inhibit viral replication, DNA polymerases (including α), and ATP
activated helicase activity [44]. This p53 protein also binds nonspecifically to DNAcellulose [44]. In particular, the p53 interact with PIP boxes on PCNA [44]. Although it’s
not clear what the nature of the interactions with PCNA, it is clear that p53 does have an
essential role in preventing genome mutations [44]. Mutations in the p53 gene is the most
commonly observed genetic deviation noted in human cancers [45]. These mutated p53
proteins have been found to lose their affinity to binding DNA, which supports the
premise that the process of p53 binding to DNA is critical to its function as a tumor
suppressor [45]. In addition, sustained cell cycle arrest of G2 phase of replication could
only be maintained when p53 was present in the cell and transcriptionally activating p21
[46]. Knockout of either p53 or p21 has been found to lead to the progression of mitosis
in cells expressing DNA instability [46]. The significant number of p53 mutations
associated with cancerous cells, the processes of DNA binding of p53 and the role of
activating the tumor suppressing p21 make p53 another DNA damage marker that should
be expressed in the presence of UV induced DNA damage [46].
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2.6 Overview and Scope of Thesis
UV exposure is a serious problem leading to millions of new NMSC cases each
year. Limitations with sunscreen, including a number of toxic side effects, have sparked
interest in safer methods to prevent UV induced DNA damage. Previous work done with
bovine SM have shown great promise in preventing other types of human cancer, with
particular emphasis on human colon cancer. This has sparked interest if this SM
component could also provide protection against NMSC. Bovine SM could potentially
provide UV protection through preventing the formation of DNA damaging radical
oxygen species during UV exposure, or helping induce apoptosis through the formation
of the tumor suppressor ceramide. In order to test the efficacy of SM, human KRTs were
gown in vitro in order to test SM treatment prior to UV exposure. UV induced DNA
damage was assessed via the expression of two of the most predominant DNA damage
biomarkers, p21 and p53. The p21 has includes both cyclin kinase inhibiting to prevent
cell growth and interactions with PCNA to halt DNA repair and induce apoptosis. The
role p53 has is more ambiguous, though p53 is the most mutation gene in cancerous cells,
upstream of p21 and believed to interact with DNA to regulate cell cycle. Both p53 and
p21 are essential to maintaining cell cycle arrest following DNA damage, giving time for
cell to repair DNA damage or commit to apoptosis, making p21 and p53 ideal markers to
assess UV induced DNA damage. Both of these DNA damage biomarker nuclear
expressions are assessed following treatment and UV exposure. The data is then analyzed
to determine if any evidence exists to support SM as having any potential to protect
against UV induced NMSC.
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Chapter 3: Methods for Protocol
3.1 Summary
KRTs were cultured using keratinocyte growth media and were plated into 8 well
plates specifically designed for imaging with an inverted microscope. SM solution was
added to half of the KRTs and the cells were allowed to incubate for 24 hours in this
media. A randomized distribution of SM treated groups was used to minimize any effects
caused between plates. Following the 24 hour incubation, the SM media was removed
and replaced with SM free media prior to UV exposure. The SM media was removed and
replacement with a fresh non-SM media prior to UV exposure to ensure that SM still
present in the media solution wasn’t reflecting the UV radiation. A UV lamp was used in
a controlled setting using appropriate personal protective equipment to expose KRTs to
302nm UV radiation. An appropriate time was calculated to expose the KRTs to
40mj/cm2. Following UV exposure, the KRTs were incubated for an additional 24 hours
prior to fixing the cells. Four KRT groups were tested in the described manner, consisting
of no SM and no UV (SM (-) UV (-)), no SM and UV (SM (-) UV (+)), SM and no UV
(SM (+) UV (-)) and SM and UV (SM (+) UV (+)) (See Figure 3.1).
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Figure 3.1 Flowchart of the KRTs protocol for each treatment group
KRTs were fixed with 3.7% paraformaldehyde following washing. All washes
were done three times with PBS. The paraformaldehyde was left in the cells for 15
minutes. A solution of triton-x was added to the KRTs to permeabilize the plasma
membrane and allow for the diffusion of reagents into the cell. This solution of triton-x
was left on for 15 minutes. The desired biomarker of interest determined the following
blocking, primary and secondary reagents. Procedures used in this experiment included
staining for p21, p53 and both p21 and p53 simultaneously (dual staining). Blocking was
added to each well and left on overnight. Removal of the blocking was followed by the
addition of the primary p21 and/or p53 antibody. This primary was left on for about 9-12
hours before being washed. Observation of p21 or p53 required the addition of the
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secondary Alexa Fluor 488 or Alexa Fluor 488 and 647 for dual staining. The secondary
was removed after an hour in the wells and then Hoechst stain [Life Technologies,
H21486] was left on for 15 minutes and was used to visualize the nucleus of each cell
(See Table 3.1). Imaging was performed on a confocal microscope at 40X allowing for
simultaneous imaging of p21 and Hoechst. Three representative images were taken for
each well in each of the four plates (total of 32 wells) and nuclear expression of p21 was
determined by overlapping Hoechst and p21 fluorescence. An automated program
determined the number of KRTs using the Hoechst stain and ImageJ was used to
manually count cells with p21 positive expression [2]. The ratio of the number of cells
with nuclear p21 expression to the total number of cells were taken for each well, and ttesting was used to determine differences between each group.
Table 3.1 Summary of reagents and concentrations within these experiments

0.1%

20 min

1%

Overnight

Dual or Single Vendor and
Staining
Catalog No.
Both
Invitrogen
Both
HFH10
Life Technologies
Both
500622

1%
1:400
1:400

Overnight
9-12 hours
9-12 hours

Dual
Single
Dual

p53

1:400

9-12 hours

Both

Secondary

AF 488
AF 647

1:400
1:400

1 hour
1 hour

Both
Dual

Hoechst

p53

1:400

15 min

Both

Process
Fixing

Reagent
Paraformaldehyde

Permeabilization Triton-X-100
10% Normal Goat
Blocking
Serum
87.5 mg/ml Normal
Donkey Serum
Primary
p21
p21

Concentration Duration
3.7%
15 min
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Abcam ab7475
Abcam ab18209
Abcam ab184640
Life Technologies
710294
Life Technologies
A11008
Abcam ab150107
Life Technologies
H21486

3.2 Keratinocyte Culturing
Aseptic technique was crucial during these experiments and was preformed within
a sterile hood. These experiments used primary human epidermal KRTs which were
isolated from normal, neonatal foreskin (PCS-200-010, ATCC Manassas, VA). These
KRTs were then cultured within a humid incubator. The incubator was set at 37°C with
approximately 5% carbon dioxide. The growth media used for the control and SM groups
consisted of a Keratinocyte Growth Kit (PCS-200-040, ATCC, Manassas, VA) mixed
with one bottle of Dermal Cell Basal Medium (PCS-200-030, ATCC, Manassas, VA),
0.5mL of Penicillin-Streptomycin-Amphotericin (PCS-999-002, ATCC, Manassas, VA),
0.5mL of Gentamicin-Amphotericin (PCS-999-025, ATCC, Manassas, VA) and 0.5mL
of Phenol Red (PCS-999-001, ATCC, Manassas, VA) and passing the mixture through a
0.22μm filter. KRTs were cultured in 8-well coverglass plates which were specially
designed for viewing with an inverted microscope. These KRTs were observed every 24
to 48 hours with a brightfield microscope to assess cell morphology, signs of
contamination and confluency. The media was also replaced during this period using
approximately 0.5 ml of media in each well. T-75 flasks of KRTs with approximately
70% confluency were passed into four of the eight well plates.
Half of the plates were treated with SM media 24 hours prior to UV exposure.
Solutions of 0.1% bovine SM were prepared and dissolved within keratinocyte growth
media for use with KRTs. Stock bovine SM was initially a yellowish powder that was
removed via tweezers and weighed to obtain the appropriate volume to create a solution
of 0.1% SM. KRTs media was then added to the weighed SM through a 0.22μm filter and
the SM was dissolved into the solution via warming and vortexing. This SM media was
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good for a month before being replaced with new media. This study consisted of four
treatment groups that were randomized as shown in Figure 3.2. Cells with odd
morphology or contamination were not used during to acquire data during the course of
this study.
SM (+) SM (-)
SM (-) SM (+)
SM (+) SM (-)
SM (-) SM (+)
Figure 3.2 Randomized group distribution for each plate. Yellow indicates UV.

3.3 UV Treatment
UV treatment was performed in the same aseptic hood used to add culture media.
All of the cells had their current media removed and replaced with SM free media,
ensuring that any UV protective effects on the SM treated group were the result of SM
incorporated into the KRTs and not the result of SM in solution. The UV box used to
safely enclose the plates was created out of black Delrin plastic sheets, which form a
rectangular box with removable top and bottom. The box is composed of four walls that
were permanently glued together and a removable top and bottom component. The top
component had a rectangular hole that allowed for the placement of the UV lamp while
the bottom component was designed to allow for the sliding of a tray holding a plate
needing UV exposure. An ABS plastic tray was designed to hold on plate at a time, and
worked in conjunction with a plate cover that ensures only half the plate receives UV
radiation (See figure 3.3).
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Figure 3.3 UV box and lamp (top) and plate tray with and without cover (bottom).
The UV box, UV lamp and UV sensor were sterilized with IPA cleaning solution.
and were brought into the sterile hood. The UV box and lamp were assembled within the
hood, and the lamp (95-0251-01, UVP, LLC, Upland, CA) was activated to 302nm for
approximately five minutes. Then the UV sensor (S120UV, ThorLabs, Newton, NJ) was
connected to the power meter (PM100,ThorLabs, Newton, NJ), was placed under the UV
lamp and the average UV exposure was calculated. The exposure time was then
determined from the area of the sensor and the average intensity to expose the cells to
40mj/cm2 of radiation, which prior work found to be the optimum dose to observe
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differences in DNA damage biomarker expression and simulates typical sunburn
conditions [7,47].

Where irradiance was calculated by taking the average intensity of the UV sensor and
dividing by the sensor area of 0.7088cm2 (diameter of 0.9cm). The exposure time was
normally around 2 minutes based on the condition of the UV lamp. The sensor was then
removed, and a plate was placed with the holding tray, a plastic cover was inserted over
the half of the plate that was not to receive UV radiation and the plate was positioned
under the lamp for the previously calculated amount of time. This was repeated for each
plate and the plates were returned to the incubator. The UV box, lamp and sensor were
disassembled and return to their proper storage area.
3.4 Fixation and Immunoflourescence Staining
Following UV exposure, the KRTs were given 24 hours to begin their DNA
damage repair pathways. After this 24 hour post-UV incubation period, each of the eight
well plates had their media contents aspirated out and were gently washed three times
with PBS. All solutions were added with pipettes by adding solutions drop wise on the
side of the wells. Then 200µl of 3.7% paraformaldehyde was added to each well to fix
the cells. The paraformaldehyde was left on each plate for approximately 15 minutes
before being removed and washed three additional times with PBS. The KRTs were then
premeabilized by adding 0.1% of the stock triton-x-100 solution diluted in PBS to each
well. Then 200µl of triton-x working solution was added to each well, left on for about
20 minutes and was removed and washed three times with PBS. The appropriate blocking
serum was diluted to 1% in PBS and 200µl of this blocking solution was added to each
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well. The blocking solution was left on for at least eight hours to help minimize offsite
binding of the secondary and to ensure the maximum ratio of signal to noise. The
blocking solution was then removed and washed three times with PBS before primary
was added. Primary consisted of a 1/400 dilution of desired antibody in PBS and 200µl of
this solution was left on the cells for about 8-10 hours. The primary was removed washed
three times with PBS and the appropriate secondary was added at the same 1/400
dilution. Table 3.2 below lists the primary and secondary antibodies that were used in
these experiments. Note that the primary and secondary antibodies were different for the
p21, p53 and both p21 and p53 stains. The antibodies used for p21 were not found to
react with the p53 antibodies and vice versa. As a result, staining for both p21 and p53,
referred here as dual staining, had appropriate blocking solutions added simultaneously
for both p21 and p53 during the blocking step. The primary regents for p21 and p53 were
added together during the primary phase and both secondary dyes were also added
together during the secondary step. The secondary was removed following an hour,
rinsed three times with PBS and Hoechst stain (5µg/ml) was diluted to 0.05% and left on
the wells for 15 minutes. The wells were then washed three more additional times and
200µl of PBS were left on each well.
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Table 3.2 List of Antibodies and Fluorescent Dyes used for each staining procedure.
Antibodies and
Fluorescence Dyes
Anti p21 raised in
Mouse
Anti p21 raised in
Rabbit
Anti p53 raised in rabbit
Donkey Anti-Mouse
Alexa Fluor 647
Goat Anti-Mouse Alexa
Fluor 488
Hoechst

Staining
Application

Antibody
Concentration

Vendor and Catalog No.

Dual Staining

1:400

Abcam ab184640

p21
Either p53 or Dual
Staining

1:400

Abcam ab18209
Life Technologies
710294

Dual Staining
p21, p53 or Dual
Staining
p21, p53 or Dual
Staining

1:400

1:400

1:400
2µg/ml

Abcam ab150107
Life Technologies
A11008
Life Technologies
H21486

3.5 Confocal Imaging
Images were then obtained for each well following completion of the
immunofluorescence protocol with an Olympus FluoView FV1000 confocal microscope
(Olympus America, Centerville, PA). The FluoView Software was configured to apply
optical filters for DAPI, Alexa Fluor 488 for either p21 or p53 staining. Simultaneous
staining of p21 and p53 required optical filters for DAPI, Alexa Fluor 488 and Alexa
Fluor 647. The 40x oil immersion objective was used to image the wells after securing
the plates within the proper mount on the stage. The cells were then put into focus using
widefield fluorescence and regions of high confluency near the center of the plates were
located. This was necessary because most of the 40mj/cm2 of UV radiation reached the
center of the well, while regions of the plate closer to the wall can potentially deflect UV
radiation lowering the effective UV dose. The speed scan was set to 4µs/pixel and image
size was set to 512 by 512. After finding a region of interest, the samples were scanned
using “XY Repeat” and were further focused to find the center plane of the nuclei of the
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KRTs. The laser power and HV were optimized for each channel to allow for clear
identification of p21 or p53 positive cells without creating too much background. The
“Sequential” feature was also used to avoid unnecessary bleed-through of channels.
Three locations in each well were selected to effectively sample the entire well. Images
were exported as TIFF files and saved for further image analysis.

Figure 3.4 The Olympus FluoView FV1000 confocal microscope used for imaging.
3.6 Image Analysis
In order to determine the ratio of p21 or p53 positive cells within each image, the
number of total cells and cells expressing nuclear p21 or p53 must be determined. The
IntenseCount program analyzed merged images and was used to determine the total
number of cells present in each well [7]. ImageJ was then used to manually place markers
in each cell that was found to be p21 or p53 positive. A user identified these positive cells
by visual inspection of the nucleus expression compared to expression within the
cytoplasm. The cells with clearly higher expression in the nucleus were counted as
positive cells and the ratio of number of positive to total number of cells in each image is
calculated. The ratio was averaged over every image taken in the well to create one data
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point for the well. Difficulties in maintaining confluency within the center of the well
following UV treatment and the potentially harsh process of staining limited the number
of samples obtained for the course of these experiments. As a results, the final sample
size was n=8, which allowed for t-testing between each group (α=0.05) using Microsoft
excel. In addition, the differences between both UV treated groups are compared via ttest (α=0.05) to determine if SM imparts any photoprotective effects. Tukey’s test was
not employed due to the assumption that every treatment group has equal variances,
which was found to not hold true for the control cases. This could be due to the relatively
the small sample size of each group and the large variance of KRTs naturally expressing
p21 and p53 due to DNA damage independent of UV radiation.
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Chapter 4: Results for Protocol
4.1 Preliminary Results
A number of factors went into optimizing the protocol discussed in the previous
section in order to obtain data to potentially support SM protecting against UV induced
DNA damage. The first major difficulty in the protocol was maintaining cell confluency
in the center of the wells. Harsh treatment while adding reagents or washing during
staining destroyed KRTs in the center of the well. The center of the well is the most
exposed, both to UV exposure and staining, making these KRTs the easiest to wash off
the plate (See Figure 4.1). However, these cells also received 40mj/cm2 of UV radiation,
whereas cells near the edges received less UV exposure, making it necessary to develop
new methods to maintain higher confluency near the center of the well. As a result, new
pipette techniques were thoroughly researched to ensure that the KRTs were treated
gently during staining. The methods adopted included gently dipping solutions on the
sides of the well when adding liquid, which improved cell viability considerably.

Figure 4.1 Regions of poor confluency near the center of the well.
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Maintaining higher confluency of KRTs was a major step towards evaluating UV
induced DNA damage, but a poor signal to noise contrast further limited the usefulness of
our data. Pictures obtained with the new methods did increase KRT confluency
considerably, but each cell was found to have nuclear expression of Alexa Fluor 488 (See
Figure 4.2). This made identification of positive or negative p21 or p53 expressing KRTs
impossible, requiring additional work to optimize the stain. Addition research found that
the blocking step was insufficient, which is why blocking concentration was increased to
1% and left on overnight. This did increase the signal to noise ratio and allow for
quantification of KRTs with positive and negative p21 or p53 expression.

Figure 4.2 Regions of poor signal to noise ratio attributed to insufficient blocking.
Another serious problem our lab group encountered was that antibodies
sometimes were deficient or impure. One of the problems encountered during dual
staining included a bad lot of p21 primary antibody, which required higher laser power to
visualize the KRTs. However, the high laser power also created background, which made
identification of p21 positive and negative KRTs difficult (See Figure 4.3). Testing the
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primary with various known working secondary stains allowed for identification of the
defect within the primary and a replacement was acquired.

Figure 4.3 Poor binding of the primary antibody.

4.2 The p21 Results
4.2.1 Representative Images
Representative images taken by the confocal microscope of the four treatment
groups are shown in Figure 4.4. The hoechst stain is blue and indicates the location of the
nucleus of each cell. The Alexa Fluor 488 is green and binds p21. Typically p21 is found
within the cytoplasm, but will be expressed in the nucleus following DNA damage.
Therefore, the bright green signal in the nuclear region indicates if the skin cells have
taken UV damage. The SM (-) UV (+) group appeared to have the highest ratio of nuclear
p21, followed by SM (+) UV (+) and significantly lower expression in the remaining no
UV groups. It was also observed that p21 was expressed primarily in the cytoplasm in the
UV (-) SM (-) group, but had much higher nuclear localization in UV (+) SM (-) group.

38

Hoechst

Alexa Fluor 488

Merged

UV (-) SM (-)

UV (+) SM (-)

UV (-) SM (+)

UV (+) SM (+)

Figure 4.4 UV Treated Sphingomyelin Groups. No SM and no UV treatment (top
row), No SM and UV treatment (2nd row), 0.1% Sphingomyelin and no UV treatment (3rd
row), and 0.1% Sphingomyelin and UV treatment (last row).Regions in red are magnified
KRTs showing p21 positive cells for UV treated KRTs and p21 negative cells for the no
UV treated KRTs.
4.2.2 Raw Data
The ratio of KRTs expressing p21 were manually counted using imageJ and the
IntenseCount program and is shown in table 4.1 below. The same trends noted in the
representative images above were seen during the data analysis. The highest expression
of p21 positive KRTs were seen with the SM (-) UV (+) group, followed by the SM (+)
UV (+), SM (+) UV (-) and SM (-) UV (-) groups. The difference between the both UV
groups were significantly more than the difference between the no UV groups.
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Table 4.1 The ratio of p21 positive cells being expressed in each treatment group
Treatment
Group
SM (-) UV (-)
SM (-) UV (+)
SM (+) UV (-)
SM (+) UV (+)

Ratio of p21 Positive
KRTs
0.045311117
0.122167707
0.038690553
0.084221973

Standard Error
0.014518851
0.008970801
0.007467327
0.0092956

4.2.3 Interpretations
The ratio of cells expressing nuclear p21 for each group is shown in Figure 4.5.
The SM (-) UV (+) treatment group was found to have the highest ratio of cells
expressing nuclear p21, followed by SM (+) UV (+), SM (-) UV (-) and SM (+) UV (-).
The data showed a significant difference in the ratio of p21 expression between both
groups at the UV dosage level and both groups without UV exposure. This supports the
initial premise that p21 is an appropriate DNA damage biomarker to observe UV induced
DNA damage. No difference between the ratios of cells expressing nuclear p21 was
observed between either groups at the no UV dosage level. This does not provide any
evidence of SM having any adverse effects on KRTs health, which is important if SM is
to ever have any therapeutic application. There was a difference between the UV (-) SM
(-) and the UV (+) SM (-) groups. This indicates that UV radiation did induce DNA
damage and that p21 was expressed in the nucleus in response to this DNA damage.
There was a significant difference between the SM (-) UV (+) and SM (+) UV (+) groups
nuclear p21 expression. This decrease in p21 expression provides evidence of SM
providing protection against UV induced DNA damage.
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Ratio of Nuclei with P21

0.14

*

0.12
0.1

*

0.08
0.06
0.04
0.02
0

SM (-) UV (-)

SM (-) UV (+)

SM (+) UV (-)

SM (+) UV (+)

Figure 4.5 UV Treated Sphingomyelin Results. The ratio of cells expressing nuclear
p21 compared to the total number of cells in each group is plotted above. (*) p < 0.05;
significant difference in ratio of cells expressing nuclear p21.

4.3 The p53 Results
4.3.1 Representative Images
The results for p53 follow a very similar trend to p21. Representative images
taken by the confocal microscope of the four treatment groups are shown in Figure 4.6.
The hoechst stain is blue and indicates the location of the nucleus of each cell. The Alexa
Fluor 488 is green and binds p53. Typically p53 is found within the cytoplasm, but will
be expressed in the nucleus following DNA damage. Therefore, the bright green signal in
the nuclear region indicates if the skin cells have taken UV damage. As shown in the p21
results, the hoechst stain is blue and the Alexa Fluor 488 is green, with the bright green
signal in the nuclear region indicating that the skin cells have taken UV damage. The SM
(-) UV (+) group appeared to have the highest ratio of nuclear p21, followed by SM (+)
UV (+) and significantly lower expression in the remaining no UV groups. It was also
observed that p53 was expressed primarily in the cytoplasm in the UV (-) SM (-) group,
but had much higher nuclear localization in UV (+) SM (-) group.
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Hoechst

Alexa Fluor 488

Merged

UV (-) SM (-)

UV (+) SM (-)

UV (-) SM (+)

UV (+) SM (+)

Figure 4.6 UV Treated Sphingomyelin Groups. No SM and no UV treatment (top
row), No SM and UV treatment (2nd row), 0.1% Sphingomyelin and no UV treatment (3rd
row), and 0.1% Sphingomyelin and UV treatment (last row).
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4.3.2 Raw Data
The ratio of KRTs expressing p25 were manually counted using imageJ
and the IntenseCount program and is shown in table 4.1 below. The highest expression of
p53 positive KRTs were seen with the SM (-) UV (+) group, followed by the SM (+) UV
(+), SM (+) UV (-) and SM (-) UV (-) groups. The difference between the both UV
groups were significantly more than the difference between the no UV groups.
Table 4.2 The ratio of p53 positive cells being expressed in each treatment group
Treatment
Group
SM (-) UV (-)
SM (+) UV (-)
SM (+) UV (+)
SM (-) UV (+)

Ratio of P53 Positive
KRTs
0.047399015
0.034474101
0.057557255
0.082643619

Standard
Error
0.015933562
0.00829868
0.006931191
0.010363842

4.3.3 Interpretations
The ratio of cells expressing nuclear p53 for each group is shown in Figure 4.7.
Similar to the trends found with p21, the SM (-) UV (+) treatment group was found to
have the highest ratio of cells expressing nuclear p53, followed by SM (+) UV (+), SM () UV (-) and SM (+) UV (-). The data showed a significant difference in the ratio of p53
expression between both groups at the UV dosage level and both groups without UV
exposure. This also supports the initial premise that p53 is an appropriate DNA damage
biomarker to observe UV induced DNA damage, which is expected due to p53 being
upstream of p21. No difference between the ratios of cells expressing nuclear p53 was
observed between either groups at the no UV dosage level. This does not provide any
evidence of SM having any adverse effects on KRTs health. There was a difference
between the UV (-) SM (-) and the UV (+) SM (-) groups. This indicates that UV
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radiation did induce DNA damage and that p53 was expressed in the nucleus in response
to this DNA damage. There was a significant difference between the SM (-) UV (+) and
SM (+) UV (+) groups nuclear p53 expression. This decrease in p53 expression provides
evidence of SM providing protection against UV induced DNA damage, which could
have applications in preventing the formation of NMSC.
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Figure 4.7 UV Treated Sphingomyelin Results. The ratio of cells expressing nuclear
p53 compared to the total number of cells in each group is plotted above. (*) p < 0.05;
significant difference in ratio of cells expressing nuclear p53.

4.4 Dual Staining Results
The results for dual stain show similar trends to both p21 and p53. Representative
images taken by the confocal microscope of the four treatment groups are shown in
Figure 4.8. The hoechst stain is blue and indicates the location of the nucleus. The Alexa
Fluor 488 is green and binds p53. The Alexa Fluor 647 is red and binds p21. As with the
data for p21 and p53 above, bright green or red signal in the nuclear region indicates if
the skin cells have taken UV damage. The SM (-) UV (+) group appeared to have the
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highest ratio of nuclear p53 and p21, followed by significantly lower expression in the
remaining groups. It was also observed that p53 was expressed primarily in the cytoplasm
in the UV (-) SM (-) group, but had much higher nuclear localization in UV (+) SM (-)
group. Only a few wells from each treatment group had images appropriate for
quantification, which made the number of samples too small for analysis. Further
optimization of the protocol should allow for more images to be obtained to confirm
these trends for dual staining.
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Figure 4.8 UV Treated Sphingomyelin Groups. No SM and no UV treatment (top
row), No SM and UV treatment (2nd row), 0.1% Sphingomyelin and no UV treatment (3rd
row), and 0.1% Sphingomyelin and UV treatment (last row).
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Chapter 5: Discussion
5.1 Overview
Identifying safer treatment alternatives to sunscreen has the potential to reduce the
number of patients diagnosed with skin cancer without the adverse side effects of
sunscreen. In particular, milk SM has been proposed to help prevent DNA damage
associated with UV exposure. This study compared the expression of p21 and p53, two
genes up-regulated by DNA damage, to assess if SM protects KRTs from UV induced
DNA damage. A monolayer of KRTs were cultured into eight well plates and were
treated with SM 24 hours prior to being exposed to 40mJ/cm2 of UVB radiation. Cells
were then stained, imaged and analyzed and the ratio of cells expressing nuclear p21 and
p53 was significantly decreased in the SM (+) UV (+) group compared to the SM (-) UV
(+) group. This decrease in both DNA damage biomarkers provides evidence to support
that SM protects KRTs from UV exposure. In addition, a significant increase in the ratio
of nuclear p21 and p53 expression was observed in the SM (-) UV (+) group when
compared to the control, which supports the use of both of these markers as an indicator
of DNA damage. Furthermore, no significant increase in either p21 or p53 intensities
were found in the SM (+) UV (+) group compared to the SM (-) UV (-) group. This in
combination with preliminary work with apoptotic and proliferative stains suggest that
SM has no detrimental effect on cellular proliferation or apoptosis, which also supports
SM as a safe treatment against DNA damage. These results suggest that SM is a safe
treatment that can provide some protection against UV exposure, but could be
insufficient to prevent all UV associated DNA damage. The hypothesis of the study was
supported by the data.
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5.2 Statistical Analysis Assumptions
The one way ANOVA test was considered for the analysis of these experiments,
but not all of the assumptions required to use one way ANOVA were met. The three
assumptions needed include 1) samples are independent, 2) responses for a given group
are normally distributed and 3) variances of populations between groups are equal. The
first criteria was addressed by separating groups between different plates and taking
random images in each well. The normalized responses are shown in the plots below (see
Figure 5.1 and 5.2). Both p21 or p53 appears to follow normalized distributions within
the confines of the 95% confidence interval, with p53 having a slightly more normalized
response due to p53 more closely following the 95% confidence interval. The last criteria
is that the samples have equal variances. The variances between groups do not appear to
be equal between every group due to the control group having very large variances
compared to the other treatment groups. As a consequence, the plots of residual
frequency also do not appear to follow a normal distribution for either p21 or p53. The
lack of equal variances might question the use of one way ANOVA and would also
invalidate the post hoc Tukey’s test. Since the control group’s large variance is
responsible for invalidating the assumptions underlying ANOVA and Tukey’s test, both
of the groups are assessed with t-tests to determine if sphingomyelin provides any
photoprotective effects against UV damage.
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Probability Plot of Ratio of p21 Positive Cells
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Figure 5.1 Residuals of p21 positive cells. A) Probability plot of p21 responses. B)
Histogram of residuals of all treatment groups.
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Probability Plot of Ratio of p53 Positive Cells
Normal - 95% CI
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Figure 5.2 Residuals of p53 positive cells. A) Probability plot of p53 responses. B)
Histogram of residuals of all treatment groups.
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5.3 Observation of p21 and p53 as Biomarkers for DNA Damage
DNA damage biomarkers p21 and p53 were ideal markers for analyzing DNA
damage due to their response following UV induced DNA damage. Nuclear expression of
p53 occurs nearly immediately following UV induced DNA damage and has been
identified as a protein involved in gene transcription, DNA synthesis and repair [48].
Many cancers have been observed to have mutated or inhibited p53 expression,
suggesting that p53 plays an important role in ensuring correct DNA synthesis and
preventing the formation of cancer. In addition, increased expression of p53 has been
linked to G2-phase arrest preventing the proliferation of potentially cancerous cells
following DNA damage, further supporting the use of p53 as an indicator of DNA
damage [9,10,11]. The nuclear expression of p21 is activated downstream of p53
indicative of DNA damage leading to inhibition of the G1 cyclins and kinases, but can
also be expressed by other pathways (i.e transforming growth factor beta) [12]. The
expression of both DNA biomarkers p21 and p53 should follow a similar expression if
DNA damage is triggering the activation of these proteins and the expression of both
markers should increase in the presence of DNA damaging radiation. The results found
during the course of this experiment supports both of these suppositions, with both p21
and p53 following similar trends and UV exposure leading to an increase in expression
for both markers.
5.4 Theories on SM Mechanism for UV Protection
Previous research in the lab suggested that exogenously added SM protects against
UV induced DNA damage in KRTs potentially through the reduction of ROS formation
within the cells [7]. This hypothesis would support SM treatment against the formation of
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NMSC by minimizing DNA damage present following UV exposure. SM is believed to
be passively incorporated into the outer leaflet of the plasma membrane, where SM can
interact with sphingomyelinases and provide integrity of the membrane [33]. SM was
also believed to play a role in degrading lipid rafts found within the plasma membrane
[33]. GM1 Ganglioside and cholesterol-rich microdomains (i.e lipid rafts) have been
shown to generate damaging radical oxygen species following UVA irradiation [33]. The
formation of radical oxygen species has been found to cause DNA damage and
potentially lead to the progression of cancer. If SM does have the ability to degrade these
lipid rafts before the KRTs are exposed to UV radiation, then the formation of radical
oxygen species would subsequently be reduced following UV exposure. This could
support SM as an anti-cancer therapy by inhibiting the production of these radical oxygen
species which should lead to less DNA damage following UV radiation [34].
Limitations with this theory include the role UVA has on NMSC development and
the consequences of dissolving lipid rafts. As previously stated, UVB is responsible for
over 80% of NMSC cases and is typically not associated with radical oxygen species
formation [34]. Although UVA radiation is primarily responsible for the remaining 20%
of NMSC cases and is known for developing radical oxygen species in UV exposed cells,
a treatment targeting UVA exposure would have much more limited application than a
treatment targeting UVB exposure. In addition, the UV lamp used in these experiments
was within the UVB range which questions why a significant decrease in both p21 and
p53 were observed if SM decreases radical oxygen species formation primarily
associated with UVA. Lipid rafts also are involved in many key physiological processes,
including regulating chemical activity of cholesterol in membranes and participate in the
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processes of signal transduction [33]. Depletion of these lipid rafts have been found to
inhibit cell signaling pathways, which could have a number of undesirable side effects
associated with this treatment if SM does indeed degrade lipid rafts. The limited
protection and potential adverse effects imparted by dissolving lipid rafts and preventing
radical oxygen species has prompted interest in determining other theories explain SM
observed UV protective properties.
Another theory on how SM might potentially protect against UV induced NMSC is
that SM leads to an increase of ceramide, which is proapoptotic factor following UV
induced cellular damage. SM has been found to increase sphingomyelinase activity,
which leads to the formation of additional ceramide production within KRTs [49].
Ceramide has been shown to be recruited to lipid rafts following cell stress and accelerate
apoptosis (see Figure 5.3), known as ceramide mediated tumor suppression [49].
Increasing the sensitivity of the KRTs to apoptotic signaling and accelerating the
apoptosis process could help ensure that potentially carcinogenic cells undergo apoptosis
instead of potentially forming NMSC. Apoptosis rates of KRTs following UVB radiation
is well documented, with apoptosis initially present eight hours following UV radiation,
peaking around 24-48 hours past UV exposure and disappears 60-72 hours later [50]. If
the increase of SM and, consequently, ceramide does indeed accelerate apoptosis of
severely damaged KRTs, then SM treated KRTs could have had more cells that have
already undergone apoptosis prior to the 24 hour time point, leading to the reduced DNA
damage biomarker expression observed here. This could suggest that SM has anti-cancer
effects by helping ensure potentially cancerous cells undergo apoptosis instead of
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forming carcinomas and faster removal of these damaged KRTs could also help
accelerate the repair process.

Figure 5.3 Role of sphingomyelin and ceramide in apoptosis [49].
5.5 Limitations and Future Work
The role of SM in preventing UV induced DNA damage or NMSC is still
relatively unknown. It is quite possible that the effect of SM is a combination of
reinforcing the plasma membrane, reducing radical oxygen species and accelerating
apoptosis of potentially carcinogenic KRTs. Limitations with this study include having
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obtained no evidence to support a mechanism on how SM provides photoprotective
properties to KRTs. Additional work with radical oxygen species detection, staining for
ceramide and the addition of quantum dots to the SM phospholipid could illuminate the
effect SM has within the cells and could allow for determination of the processes behind
SM capacity to protect against UV induced DNA damage. Additional limitations with
this study include not conducting extensive proliferation or apoptotic staining to ensure
safe use of SM. Although preliminary tests have not observed any adverse effects with
application of SM, any future therapeutic application of SM will require extensive tests to
evaluate the safety of exogenous SM. Last, these experiments are only observing DNA
damage biomarkers on a simple monolayer of KRTs. Future work should include
analyzing UV induced DNA damage on skin tissue constructs to verify trends found in
this study. Further work could also involve testing orally administered SM in an animal
model to determine if SM application actually reduces precursor legions and tumor
formation following prolonged UV exposure.
5.6 Conclusions
Bovine milk sphingomyelin was found to lead to a decrease in DNA damage
biomarkers p21 and p53 following UV irradiation in human KRTs, which is indicative of
preventing UV induced DNA damage. Both p21 and p53 markers showed a significant
decrease in expression between the SM (+) UV (+) and SM (-) UV (+) groups providing
evidence of SM imparting photoprotective effects to SM. The no UV groups had no
significant difference in p21 and p53 expression, which provides no evidence of SM
having adverse effects on the KRTs. The mechanism of how SM provides UV protection
is still unknown. Different mechanisms, including preventing radical oxygen species,
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providing structural support and leading to the increased production of the ceramide
mediated tumor suppression, have been proposed to support SM as a potential anti-cancer
treatment. However, additional studies will have to be conducted to determine the
accuracy of these proposed theories. In addition, more work will have to be conducted to
ensure that exogenous SM is safe and effective. These tests could include proliferation
and apoptotic stains on monolayers of KRTs, DNA damage biomarker expression within
skin tissue constructs and animal models to determine effectiveness. This work found that
SM treated KRTs reduced the expression of both p21 and p53 compared to KRTs without
SM in the presence of UV, which could potentially support further research into SM as a
treatment to safely prevent the onset of NMSC.
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